Skip to main content

Advertisement

SpringerLink
Log in

BPTF Associated with EMT Indicates Negative Prognosis in Patients with Hepatocellular Carcinoma

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Background/Aims

Epithelial-mesenchymal transition (EMT) plays an important role in hepatocellular carcinoma (HCC) dissemination. Bromodomain PHD-finger transcription factor (BPTF) could regulate embrogenesis and stem cell differentiation, and it may be involved in tumor progression and EMT. In this study, we aimed to determine BPTF, E-cadherin and vimentin expression in tumor tissues and the clinical significance in relation to HCC.

Methods

The BPTF, vimentin and E-cadherin expression of 106 HCC tissue samples was examined by immunohistochemical staining.

Results

BPTF and vimentin showed high expression and E-cadherin showed low expression in HCC. BPTF is associated with the tumor number, vascular invasion, Edmondson-Steiner grade, TNM stage and recurrence (P < 0.05). Vimentin is positively correlated with tumor size, tumor number, vascular invasion, Edmondson-Steiner grade, TNM stage and recurrence (P < 0.05). E-cadherin is negatively correlated with tumor number, Edmondson-Steiner grade, TNM stage and recurrence (P < 0.05). Survival analysis has shown that high expression of BPTF and vimentin indicates poorer overall and disease-free survival (P < 0.05). Multivariate analysis shows that BPTF is an independent marker for survival prediction (P = 0.015). Additionally, high BPTF expression is correlated with high vimentin expression and low E-cadherin expression (P < 0.05).

Conclusion

High BPTF expression may be an independent marker for survival prediction in HCC patients and is probably involved in EMT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.

    Article  PubMed  Google Scholar 

  2. de Lope CR, Tremosini S, Forner A, Reig M, Bruix J. Management of HCC. J Hepatol. 2012;56:S75–S87.

    Article  PubMed  Google Scholar 

  3. Wysocka J, Swigut T, Xiao H, et al. A PHD finger of NURF couples histone H3 lysine 4 trimethylation with chromatin remodelling. Nature. 2006;442:86–90.

    CAS  PubMed  Google Scholar 

  4. Jones MH, Hamana N, Shimane M. Identification and characterization of BPTF, a novel bromodomain transcription factor. Genomics. 2000;63:35–39.

    Article  CAS  PubMed  Google Scholar 

  5. Jordan-Sciutto KL, Dragich JM, Caltagarone J, Hall DJ, Bowser R. Fetal Alz-50 clone 1 (FAC1) protein interacts with the Myc-associated zinc finger protein (ZF87/MAZ) and alters its transcriptional activity. Biochemistry. 2000;39:3206–3215.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  6. Li H, Ilin S, Wang W, et al. Molecular basis for site-specific read-out of histone H3K4me3 by the BPTF PHD finger of NURF. Nature. 2006;442:91–95.

    Article  CAS  PubMed  Google Scholar 

  7. Landry J, Sharov AA, Piao Y, et al. Essential role of chromatin remodeling protein Bptf in early mouse embryos and embryonic stem cells. PLoS Genet. 2008;4:e1000241.

    Article  PubMed Central  PubMed  Google Scholar 

  8. Goller T, Vauti F, Ramasamy S, Arnold HH. Transcriptional regulator BPTF/FAC1 is essential for trophoblast differentiation during early mouse development. Mol Cell Biol. 2008;28:6819–6827.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  9. Buganim Y, Goldstein I, Lipson D, et al. A novel translocation breakpoint within the BPTF gene is associated with a pre-malignant phenotype. PLoS ONE. 2010;5:e9657.

    Article  PubMed Central  PubMed  Google Scholar 

  10. Kim K, Punj V, Choi J, et al., Gene dysregulation by histone variant H2A.Z in bladder cancer. Epigenetics Chromatin. 2013;6:34.

  11. Xiao F, Kim YC, Snyder C, et al. Genome instability in blood cells of a BRCA1+ breast cancer family. BMC Cancer. 2014;14:342.

    Article  PubMed Central  PubMed  Google Scholar 

  12. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest. 2009;119:1420–1428.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  13. Craene BD, Berx G. Regulatory networks defining EMT during cancer initiation and progression. Nat Rev Cancer. 2012;13:97–110.

    Article  Google Scholar 

  14. Fan CC, Wang TY, Cheng YA, et al. Expression of E-cadherin, Twist, and p53 and their prognostic value in patients with oral squamous cell carcinoma. J Cancer Res Clin Oncol. 2013;139:1735–1744.

    Article  CAS  PubMed  Google Scholar 

  15. Mulder KW, Wang X, Escriu C, et al. Diverse epigenetic strategies interact to control epidermal differentiation. Nat Cell Biol. 2012;14:753–763.

    Article  CAS  PubMed  Google Scholar 

  16. Dai X, Deng S, Wang T, et al. Associations between 25 lung cancer risk-related SNPs and polycyclic aromatic hydrocarbon-induced genetic damage in coke oven workers. Cancer Epidemiol Biomarkers Prev. 2014;23:986–996.

    Article  CAS  PubMed  Google Scholar 

  17. Lim J, Thiery JP. Epithelial-mesenchymal transitions: insights from development. Development. 2012;139:3471–3486.

    Article  CAS  PubMed  Google Scholar 

  18. Maheswaran T, Rushbrook SM. Epithelial-mesenchymal transition and the liver: role in hepatocellular carcinoma and liver fibrosis. J Gastroenterol Hepatol. 2012;27:418–420.

    Article  CAS  PubMed  Google Scholar 

  19. Choi SS, Diehl AM. Epithelial-to-mesenchymal transitions in the liver. Hepatology. 2009;50:2007–2013.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  20. Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell. 2009;139:871–890.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors thank Fan Zheng for polishing the English in the revision.

Conflicts of interest

There are no conflicts of interest.

Author information

Authors and Affiliations

  1. Department of General Surgery, Affiliated Nanhua Hospital of University of South China, 336 South Dongfeng Road, Hengyang, 421002, Hunan Province, China

    Shuai Xiao, Longfei Liu, Min Fang, Xiaojun Zhou, Xiuda Peng, Jianwu Long & Xianzhou Lu

Authors
  1. Shuai Xiao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Longfei Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Min Fang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Xiaojun Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Xiuda Peng
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jianwu Long
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Xianzhou Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Xianzhou Lu.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xiao, S., Liu, L., Fang, M. et al. BPTF Associated with EMT Indicates Negative Prognosis in Patients with Hepatocellular Carcinoma. Dig Dis Sci 60, 910–918 (2015). https://doi.org/10.1007/s10620-014-3411-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-014-3411-0

Keywords

Search

Navigation